News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current NAMS market cap is 1.95B. The company's latest EPS is EUR -1.9821 and P/E is -11.06.
| Quarter End | |
|---|---|
| EUR (€) | |
| Total Revenue | |
| Operating Income | |
| Net Income |
| Year End December 30 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Revenue | 14.09M |
| Operating Income | -182.69M |
| Net Income | -176.94M |
| Quarter End | |
|---|---|
| EUR (€) | |
| Total Assets | |
| Total Liabilities | |
| Total Equity |
| Year End December 30 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Assets | 347.1M |
| Total Liabilities | 58.7M |
| Total Equity | 288.39M |
| Market Cap | 1.95B |
| Price to Earnings Ratio | -11.06 |
| Price to Sales Ratio | 138.91 |
| Price to Cash Ratio | 5.75 |
| Price to Book Ratio | 6.78 |
| Dividend Yield | - |
| Shares Outstanding | 89.27M |
| Average Volume (1 week) | 120.49k |
| Average Volume (1 Month) | 232.2k |
| 52 Week Change | 47.64% |
| 52 Week High | 26.35 |
| 52 Week Low | 5.6326 |
| Spread (Intraday) | 2.65 (11.59%) |
| Company Name | NewAmsterdam Pharma Company NV |
| Address |
gooimeer 2-35 naarden, north holland 1411 DC |
| Website | https://www.newamsterdampharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
